Skip to search formSkip to main contentSkip to account menu

CG53135

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

FGF20 protein, human
velafermin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant
Goals of workThe objective of this study was to evaluate the safety and tolerability of velafermin in patients at risk of… 
2005
2005
Single-Dose Prevention or Short-Term Treatment with Fibroblast Growth Factor-20 (CG53135-05)Reduces the Severity and Duration of Oral Mucositis.
Oral mucositis (OM) is a treatment-limiting condition associated with myelosupressive chemotherapy and radiation therapy. The… 
2005
2005
Phase I trial of CG53135–05 to prevent mucositis in patients undergoing high-dose chemotherapy (HDCT) and autologous peripheral blood stem cell transplantation (PBSCT)
6656 Background: Mucositis is a painful side effect of many transplant conditioning regimens. A new class of drugs in the… 
2005
2005
Phase I trial of CG53135-05 to prevent mucositis in patients undergoing high-dose chemotherapy (HDCT) and autologous peripheral blood stem cell transplantation (PBSCT)
2004
2004
Phase I Trial of CG53135-05 to Prevent Mucositis in Patients Undergoing High-Dose Chemotherapy (HDCT) and Autologous Peripheral Blood Stem Cell Transplantation (PBSCT).
Mucositis is a painful side effect of many transplant conditioning regimens used in HDC and PBSCT. This complication often… 
2004
2004
Safety, Tolerability, and Pharmacokinetic Assessment of CG53135 Administered Intravenously in Patients with Advanced (Stage 4) Cancer (Single Rising-Dose Tolerance).
Oral mucositis (OM) is a common complication in cancer patients receiving chemotherapy (CT). OM is characterized by damage to the… 
2003
2003
Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositis.
PURPOSE The purpose of this study was to evaluate the activity of CG53135 (FGF-20), a protein with in vitro mitogenic activity on… 
2003
2003
Preclinical Characterization of CG 53135 ( FGF-20 ) in Radiation and Concomitant Chemotherapy / Radiation-induced Oral Mucositis
Purpose: The purpose of this study was to evaluate the activity of CG53135 (FGF-20), a protein with in vitro mitogenic activity… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)